Nuclear expression of WRAP53β is associated with a positive response to radiotherapy and improved overall survival in patients with head and neck squamous cell carcinoma

Oral Oncology

Volumn 51, Issue 1, 2015, Pages 24-30

  Garvin, Stina ^a   Tiefenböck, Katharina ^b   Farnebo, Lovisa ^b   Thunell, Lena K ^a   Farnebo, Marianne ^c   Roberg, Karin ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of ENT Head and Neck Surgery County Council of Östergötland ^*  (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Head and neck cancer; Predictive factors; Radiotherapy; Survivin; WRAP53

Indexed keywords

NUCLEAR PROTEIN; PROTEIN WRAP53BETA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; TELOMERASE; TELOMERASE CAJAL BODY PROTEIN 1, HUMAN; TUMOR MARKERS, BIOLOGICAL;

ADULT; AGED; ALLELE; ARTICLE; CANCER CELL LINE; CANCER PATIENT; CANCER RADIOTHERAPY; CELL DEATH; CLINICAL ARTICLE; CLONOGENIC ASSAY; DOWN REGULATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TUMOR BIOPSY; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; HEAD AND NECK NEOPLASMS; HUMANS; METABOLISM; PHYSIOPATHOLOGY; SURVIVAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84920545731     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.10.003     Document Type: Article

References (21)

1. Mahmoudi S, Henriksson S, Corcoran M, Mendez-Vidal C, Wiman KG, Farnebo M. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 2009;33:462-71.
2. Mahmoudi S, Henriksson S, Weibrecht I, Smith S, Soderberg O, Stromblad S, et al. WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol 2010;8:e1000521.
3. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 2009;323:644-8.
4. Tycowski KT, Shu MD, Kukoyi A, Steitz JA. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. Mol Cell 2009;34:47-57.
5. Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev 2011;25:11-6.
6. Alter BP, Olson SB. Wilms tumor, AML, and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia. Pediatr Blood Cancer 2010;54:488 (author reply 9).
7. Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009;69:2349-57.
8. Garcia-Closas M, Kristensen V, Langerod A, Qi Y, Yeager M, Burdett L, et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer J Int du Cancer. 2007;121:2532-8.
9. Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, Li G, et al. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis 2009;30:50-8.
10. Mahmoudi S, Henriksson S, Farnebo L, Roberg K, Farnebo M. WRAP53 promotes cancer cell survival and is a potential target for cancer therapy. Cell Death Dis 2011;2:e114.
11. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol 2006;24:5630-6.
12. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol: J Eur Soc Ther Radiol Oncol 2010;94:30-5.
13. Wittekindt C, Gultekin E, Weissenborn SJ, Dienes HP, Pfister HJ, Klussmann JP. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Oto-Rhino-Laryngo 2005;62:72-80.
14. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010;28:4142-8. http://dx.doi.org/10.1200/JCO.2010.29.2904.
15. Jedlinski A, Ansell A, Johansson AC, Roberg K. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 2013;42:26-36.
16. Farnebo L, Jerhammar F, Vainikka L, Grenman R, Norberg-Spaak L, Roberg K. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines. Oncol Rep 2008;20:453-61.
17. Medrek K, Magnowski P, Masojc B, Chudecka-Glaz A, Torbe B, Menkiszak J, et al. Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. Mol Biol Rep 2012.
18. Farnebo L, Tiefenbock K, Ansell A, Thunell LK, Garvin S, Roberg K. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in Head and Neck squamous cell carcinoma patients. Int J Cancer J Int du Cancer 2013.
19. Zhang H, Wang DW, Adell G, Sun XF. WRAP53 is an independent prognostic factor in rectal cancer - a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients. BMC Cancer 2012;12:294.
20. Berardinelli F, Nieri D, Sgura A, Tanzarella C, Antoccia A. Telomere loss, not average telomere length, confers radiosensitivity to TK6-irradiated cells. Mutat Res 2012;740:13-20.
21. McCaul JA, Gordon KE, Minty F, Fleming J, Parkinson EK. Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells. Oral Oncol 2008;44:261-9.